brimonidine tartrate has been researched along with Corneal Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chikama, T; Hayashi, K; Kiuchi, Y; Shinji, K; Yokota, C | 1 |
| Kolomeyer, NN; Meghpara, B; Purgert, RJ | 1 |
| Gilbert, DD; Walter, KA | 1 |
| Barney, NP; Lee, CH; Murphy, CJ; Reid, TW; Taylor, PB; Whiteman, AL | 1 |
1 review(s) available for brimonidine tartrate and Corneal Diseases
| Article | Year |
|---|---|
Inflammatory Cells and Lipid Deposits Detected by
Topics: Brimonidine Tartrate; Corneal Diseases; Humans; Lipids; Microscopy, Confocal; Ophthalmic Solutions | 2023 |
3 other study(ies) available for brimonidine tartrate and Corneal Diseases
| Article | Year |
|---|---|
Corneal subepithelial infiltrates associated with brimonidine use.
Topics: Brimonidine Tartrate; Corneal Diseases; Epithelium, Corneal; Humans | 2020 |
The adverse effect of perioperative brimonidine tartrate 0.2% on flap adherence and enhancement rates in laser in situ keratomileusis patients.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Brimonidine Tartrate; Corneal Diseases; Corneal Stroma; Female; Humans; Keratomileusis, Laser In Situ; Male; Middle Aged; Ophthalmic Solutions; Preoperative Care; Quinoxalines; Refractive Surgical Procedures; Retrospective Studies; Surgical Flaps; Tissue Adhesions; Visual Acuity | 2001 |
Substance P, insulinlike growth factor 1, and surface healing.
Topics: Aged; Anti-Bacterial Agents; Antihypertensive Agents; Brimonidine Tartrate; Corneal Diseases; Drug Therapy, Combination; Epithelium, Corneal; Female; Humans; Insulin-Like Growth Factor I; Keratoplasty, Penetrating; Ophthalmic Solutions; Polymyxin B; Quinoxalines; Substance P; Wound Healing | 2002 |